Home > Balance Sheet > DIVIS LABORATORIES

DIVIS LABORATORIES
Sundry Debtors

    Back to Balance Sheet
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹2,156 Cr₹1,793 Cr₹2,424 Cr₹1,677 Cr₹1,413 Cr

What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?

The latest Sundry Debtors ratio of DIVIS LABORATORIES is ₹2,156 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹2,156 Cr
Mar2023₹1,793 Cr
Mar2022₹2,424 Cr
Mar2021₹1,677 Cr
Mar2020₹1,413 Cr

How is Sundry Debtors of DIVIS LABORATORIES Trending?

Years Sundry Debtors % Change
Mar2024 ₹2,156 Cr
20.25
Mar2023 ₹1,793 Cr
-26.03
Mar2022 ₹2,424 Cr
44.58
Mar2021 ₹1,677 Cr
18.62
Mar2020 ₹1,413 Cr -

Compare Sundry Debtors of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹183,289.3 Cr 1.4% 4.1% 50.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,284.0 Cr -0% -0.4% 10.2% Stock Analytics
CIPLA ₹122,253.0 Cr 0.5% 1.6% 1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,988.0 Cr -1.2% 7.1% 18.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr 1.7% 1.2% 1.5% Stock Analytics
MANKIND PHARMA ₹100,677.0 Cr 5% 3.3% 11% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

1.4%

4.1%

50.3%

SENSEX

-0.7%

3%

5%


You may also like the below Video Courses